These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27013967)

  • 1. Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia.
    Milleit B; Smesny S; Rothermundt M; Preul C; Schroeter ML; von Eiff C; Ponath G; Milleit C; Sauer H; Gaser C
    Front Cell Neurosci; 2016; 10():33. PubMed ID: 27013967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voxel-based morphometric analysis of gray matter in first episode schizophrenia.
    Kubicki M; Shenton ME; Salisbury DF; Hirayasu Y; Kasai K; Kikinis R; Jolesz FA; McCarley RW
    Neuroimage; 2002 Dec; 17(4):1711-9. PubMed ID: 12498745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter abnormalities in subjects at ultra high-risk for schizophrenia and first-episode schizophrenic patients.
    Witthaus H; Brüne M; Kaufmann C; Bohner G; Ozgürdal S; Gudlowski Y; Heinz A; Klingebiel R; Juckel G
    Schizophr Res; 2008 Jul; 102(1-3):141-9. PubMed ID: 18515047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study.
    Whitford TJ; Grieve SM; Farrow TF; Gomes L; Brennan J; Harris AW; Gordon E; Williams LM
    Am J Psychiatry; 2007 Jul; 164(7):1082-9. PubMed ID: 17606660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study.
    Steiner J; Bernstein HG; Bielau H; Farkas N; Winter J; Dobrowolny H; Brisch R; Gos T; Mawrin C; Myint AM; Bogerts B
    J Psychiatr Res; 2008 Aug; 42(10):868-76. PubMed ID: 18001771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter alterations in first episode treatment-naïve patients with deficit schizophrenia: a combined VBM and DTI study.
    Lei W; Li N; Deng W; Li M; Huang C; Ma X; Wang Q; Guo W; Li Y; Jiang L; Zhou Y; Hu X; McAlonan GM; Li T
    Sci Rep; 2015 Aug; 5():12994. PubMed ID: 26257373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase A2 activity is associated with structural brain changes in schizophrenia.
    Smesny S; Milleit B; Nenadic I; Preul C; Kinder D; Lasch J; Willhardt I; Sauer H; Gaser C
    Neuroimage; 2010 Oct; 52(4):1314-27. PubMed ID: 20478385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gray and white matter changes and their relation to illness trajectory in first episode psychosis.
    Keymer-Gausset A; Alonso-Solís A; Corripio I; Sauras-Quetcuti RB; Pomarol-Clotet E; Canales-Rodriguez EJ; Grasa-Bello E; Álvarez E; Portella MJ
    Eur Neuropsychopharmacol; 2018 Mar; 28(3):392-400. PubMed ID: 29338891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter abnormalities in first-episode schizophrenia: a combined structural MRI and DTI study.
    Chan WY; Yang GL; Chia MY; Lau IY; Sitoh YY; Nowinski WL; Sim K
    Schizophr Res; 2010 Jun; 119(1-3):52-60. PubMed ID: 20056394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum S100B: A proxy marker for grey and white matter status in the absence and presence of (increased risk of) psychotic disorder?
    van der Leeuw C; Peeters S; Gronenschild E; Michielse S; Verbeek M; Menheere P; van Os J; Marcelis M;
    PLoS One; 2017; 12(3):e0174752. PubMed ID: 28358925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF Serum Levels are Associated With White Matter Microstructure in Schizophrenia - A Pilot Study.
    Hammans C; Neugebauer K; Kumar V; Mevissen L; Sternkopf MA; Novakovic A; Wensing T; Habel U; Abel T; Nickl-Jockschat T
    Front Psychiatry; 2020; 11():31. PubMed ID: 32153434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls.
    Witthaus H; Kaufmann C; Bohner G; Ozgürdal S; Gudlowski Y; Gallinat J; Ruhrmann S; Brüne M; Heinz A; Klingebiel R; Juckel G
    Psychiatry Res; 2009 Sep; 173(3):163-9. PubMed ID: 19616415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.
    Qi LY; Xiu MH; Chen DC; Wang F; Kosten TA; Kosten TR; Zhang XY
    Neurosci Lett; 2009 Sep; 462(2):113-7. PubMed ID: 19539717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry.
    Job DE; Whalley HC; McConnell S; Glabus M; Johnstone EC; Lawrie SM
    Neuroimage; 2002 Oct; 17(2):880-9. PubMed ID: 12377162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Longitudinal Study of Alterations of S100B, sRAGE and Fas Ligand in Association to Olanzapine Medication in a Sample of First Episode Patients with Schizophrenia.
    Gerasimou C; Tsoporis JN; Siafakas N; Hatziagelaki E; Kallergi M; Chatziioannou SN; Parker TG; Parissis J; Salpeas V; Papageorgiou C; Rizos E
    CNS Neurol Disord Drug Targets; 2018; 17(5):383-388. PubMed ID: 29875007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM.
    Mané A; Falcon C; Mateos JJ; Fernandez-Egea E; Horga G; Lomeña F; Bargalló N; Prats-Galino A; Bernardo M; Parellada E
    Schizophr Res; 2009 Oct; 114(1-3):136-43. PubMed ID: 19683418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Patterns of White Matter Abnormalities in Medication-Naive Patients With First-Episode Schizophrenia Revealed by Diffusion Tensor Imaging and Cluster Analysis.
    Sun H; Lui S; Yao L; Deng W; Xiao Y; Zhang W; Huang X; Hu J; Bi F; Li T; Sweeney JA; Gong Q
    JAMA Psychiatry; 2015 Jul; 72(7):678-86. PubMed ID: 25993492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: a VBM study.
    Nenadic I; Dietzek M; Schönfeld N; Lorenz C; Gussew A; Reichenbach JR; Sauer H; Gaser C; Smesny S
    Schizophr Res; 2015 Feb; 161(2-3):169-76. PubMed ID: 25497442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia.
    Chen S; Tian L; Chen N; Xiu M; Wang Z; Yang G; Wang C; Yang F; Tan Y
    Psychiatry Res; 2017 Jan; 247():6-11. PubMed ID: 27863321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficits in Neurite Density Underlie White Matter Structure Abnormalities in First-Episode Psychosis.
    Rae CL; Davies G; Garfinkel SN; Gabel MC; Dowell NG; Cercignani M; Seth AK; Greenwood KE; Medford N; Critchley HD
    Biol Psychiatry; 2017 Nov; 82(10):716-725. PubMed ID: 28359565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.